DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

22.83 0.61 (2.75%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $22.83 2.75%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $21.88
Previous Close $22.22
Daily Range $21.79 - $23.26
52-Week Range $12.12 - $46.27
Market Cap $934.3M
P/E Ratio -7.43
Dividend (Yield) $0.00 (0.0%)
Volume 1,039,636
Average Daily Volume 1,399,437
Current FY EPS -$3.60

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary Rss Feed

Should Ebola Fear... Tobacco?

Ebola vaccine production could get a lift thanks to tobacco plants.

Ebola Stock Fallout Severe on Monday

Detailed Analysis Of Sarepta's Ebola Virus Cocktail: Full Phase I Clinical Trial Analysis For Non-Sc

Detailed Analysis Of Sarepta's Ebola Virus Cocktail: Full Phase I Clinical Trial Analysis For Non-Scientists

Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results

Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results for Possible Ebola Treatment

Sector Update: Health Care

Ebola Stocks Move in Different Directions

Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

Benzinga's Top #PreMarket Gainers

Ebola Stocks on the Move

Ebola: Is The Cure Out There?

See More SRPT News...

SRPT's Top Competitors

SRPT $22.83 (2.75%)
Current stock: SRPT
AMGN $137.51 (2.86%)
Current stock: AMGN
GILD $102.21 (1.45%)
Current stock: GILD
BIIB $311.41 (1.53%)
Current stock: BIIB